Chemoradiotherapy for uterine cancer : current status and perspectives
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-12-01
著者
-
Kuzuya Kazuo
Department Of Gyneclogy
-
Kuzuya Kazuo
Department Of Gynecology Aichi Cancer Center Hospital
-
Kuzuya Kazuo
Department Of Gynecology Aichi Caner Center Hospital
関連論文
- Comparative Case-referent Study of Risk Factors among Hormone-related Female Cancers in Japan
- Smoking and Dietary Risk Factors for Cervical Cancer at Different Age Group in Japan
- Subsite (cervix/endometrium)-specific Risk and Protective Factors in Uterus Cancer
- Salvage treatment with docetaxel for recurrent epithelial ovarian cancer
- Optimal doses of paclitaxel and carboplatin combination chemotherapy for ovarian cancer: a phase I modified continual reassessment method study
- 3-Hour infusion of single-agent paclitaxel for recurrent ovarian cancer
- Chemoradiotherapy for uterine cancer : current status and perspectives
- EVALUATION OF CA125 AS A CIRCULATING TUMOR MARKER FOR OVARIAN CANCER
- P1-IS-35 Clear cell carcinoma of the ovary : retrospective analysis of Japan Clear Cell Carcinoma Study
- Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin : retrospective analysis
- IS-15 Patients with stage IIIc ovarian clear cell carcinoma upstaged by lymph node metastasis have similar survival to other stage III clear cell carcinoma patients(Group2 Oncology2,International Session)